Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 16, Art. 76 (pp. 834-849)    |    2015       

»

Pressured itraperitoneal aerosol chemotherapy – a new effective way of treatment of implantation metastasises (Review)

A.A. ZAKHARENKO, A.S. NATKHA, A.A. TRUSHIN, M.A. BELYAEV, O.A.TEN, I.N. DANILOV, K.N. VOVIN.

I.P.Pavlov First Saint Petersburg State Medical University

Brief summary

ne of unresolved problems in modern oncology still remains a question of treatment of implantation metastases of malignant tumors of a digestive tract. Such methods as HIPEC and photodynamic therapy in combination with cytoreductive operations can't provide fully the acceptable results of treatment of these patients. New method of treatment of peritoneal carcinomatosis – pressurized intraperitoneal aerosol chemotherapy shows the encouraging results both at palliative, and at medical use.


Key words

peritoneal carcinomatosis, chemotherapy, malignant tumors, cytoreductive surgery, HIPEC, photodynamic therapy, pressurized intraperitoneal aerosol chemotherapy

Reference list

1. Petrovskaya N.A. Peritonealnii kanceromatoz: obzor klinicheskih i eksperimentalnih dannih // Onkologicheskii jyrnal, 2009. – T.3. – №2. – S.99-105.


2. Cotte E., Passot G., Gilly F.N., Glehen O. Selection of patients an staging of peritoneal surface malignancies // World J. Gastrointest. Oncol. 2010. - №. 2 (1). - P. 31–35.


3. Deraco M., Santoro N., Carraro O., Inglese M.G., Rebuffoni G.,Guadagni S., Somers D.C., Vaglini M. Peritoneal carcinomatosis: feature of dissemination. A review // Tumori. 1999. - №. 85. P. 1–5.


4. Shpenkova A.A. Rak yaichnikov: Effektivnost lecheniz v zavisimosti ot gradacii karcinomatoza, ili Nereshennie voprosi stadirovaniya // Vestnik Novgorodskogo gosydarstvennogo yniversiteta. 2010. - № 59. - S. 116–120.


5. Sugarbaker P. H. Overview of peritoneal carcinomatosis // Cancerologia. – 2008. – №. 3 - P. 119-124.


6. Peritoneal carcinomatosis from non-gynecologic malignancies B. Sadeghi [et al.] / // Cancer. – 2000. – №. 88, N 2. – P. 358–363.


7. Maksimenko A.N. Hiryrgicheskaya anatomiya jivota // Izd-vo: Medicina. 1972. – 688 s.


8. Tsilibary E.C. Wissing Lymphatic absorption from peritoneal cavity: regulation of patency of mesothelial stomata. // Microvasc. Res., 1983. – Vol.25. – №1. – P.22-39.


9. Ivanova V.F. Rol mezoteliya parietalnoi brushini v processe vsasivaniya istinnih rastvorov i vzvesi tyshi iz brushnoi polosti // Bul. eksper. biol. i med., 1986. – Vip.10. – S.1258-1261.


10. Chaffanjon P.C. Omental anatomy of non-human primates. // Surg. Radiol. Anat., 2005. – Vol. 27. – №4. – P.287-291.


11. Borodin U.I., Grigorev V.N., Letyagin A.U. // Morfologiya limfaticheskoi sistemi. Nayka. Novosibirsk, 1987. – 120 s.


12. Beelen R.H.J. The cellular composition of omentum milky spots and the ultrastructure of milky spot macrofages and reticulum cells. // J. Reticuculoendotel. Soc., 1980. – № 28. – P.585-599.


13. Banin V.V. Fiziologicheskoe znachenie gradienta sosydistoi pronicaemosti v brushine // Mehanizmi podderjaniya gomeostaza v sisteme mikrocirkylyacii. Pod red. I.I.Novikova i Ya.L. Karaganova. – M., 1981. – S.116-125.


14. Korablev A.V. Petlevidnii rost sosydov kak osnovopolagaushii princip vaskylogeneza // Arhiv AGE, 1990. – T. 99. – № 10. – S.45-52.


15. Baez S. B. Kesponse in the microcirculation / Fed. Proc. – 1968. – №. 27. – P.1410-1415.


16. Flessner M.F. The importance of the interstitium in peritoneal transport / Perit. Dial. Int., 1996. – № 16. – P.76-79.


17. Baron M.A. Reaktivnie stryktyri vnytrennih obolochek. L.: Medgiz, 1949. – 458 s.


18. Baron M.A. Lokalizaciya sosydov v tolshe serozi i ee barernaya fynkciya // Sb. rabot po fiziologii. M., 1939. – S.3 - 24.


19. Borisov A.V. Teoriya konstrykcii limfangiona: Obzor // Morfologiya. 1997. – № 5. – S. 7-17.


20. Healy J.C. The peritoneum, mesenteries and omenta: normal anatomy and pathological processes. // Eur. Radiol., 1998. – Vol.8. – №6. – P.886-900.


21. Shinohara H., Kominami R., Taniguchi Y. et al. The distribution and morphology of lymphatic vessels on the peritoneal surface of the adult human diaphragm, as revealed by an ink-absorption method // Okajimas Folia Anat. Jpn., 2003. – Vol.79. – №6. – P.175-183.


22. Hood J.D., Cheresh D.A.Role of integrins in cell invasion and migration // Nat. Rev. Cancer. 2002. Vol. 2. P. 91–10.


23. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? // Nat. Rev. Cancer. 2007. Vol. 7 (6). P. 415–428.


24. Thiery J.P.Epithelial-mesenchymal transitions in tumour progression // Nat. Rev. Cancer. 2002. Vol. 2. P. 442–45.


25. Ceelen W.P., Hesse U., Hemptinne V., Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intraabdominal cancer // Brit. J. Surg. 2000. - Vol. 87. - P. 1006–1015.


26. Odishelidze N.V., Chistyakov S.S., Gabyniya Z.R. Znachenie diagnostiki sybklinicheskoi intraperitonealnoi disseminacii y bolnih rakom jelydka // Rossiiskii medicinskii jyrnal. Prilojenie Onkologiya. 2011. - T. 2.- S. 4.


27. Elias D.,Glehen O., Pocard M., Quenet F., Goéré D., Arvieux C., Rat P., Gilly F. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix // Ann. Surg. 2010. - Vol. 251 (5). - P. 896–901.


28. Sugerbaker P.N., Buon J., Management of peritoneal metastases - Basic concepts. 2015 May. - 20 Suppl. 1. - p. 2-11.


29. Roviello F., Pinto E., Corso G., et al. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer // J Surg Oncol. 2010. - № 102(6). - 663-70.


30. Davidov M.I., Ter-Ovanesov M.D., Byidenok U.V., Polockii B.E., Gorbynova V.A., Abdyllaev A.G. Gipertermicheskaya intraoperacionnaya intraperitonealnaya himioterapiya pri rake jelydka: syshestvyet li realnaya vozmojnost izmenit prognoz? // Vestn. RONC im. N.N. Blohina RAMN. – 2010. – T.21, № 1. – S. 11–20.


31. Kitaev A.V., Petrov V.P., Zyev V.K., Lazarev G.V., Leonov S.V. Opit primeneniya intraoperacionnoi gipertermicheskoi himioterapii v lechenii bolnih kolorektalnim i ovarialnim rakom // Sbornik materialov IV mejregionalnoi naychno-prakticheskoi konferencii «Novie tehnologii, primenenie v klinicheskoi praktike». – M., 2008. – S. 82-83.


32. Sugarbaker PH, Schellinx ME, Chang D, Koslowe P, von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J. Surg. 1996. - № 20. – R. 585–592.


33. Witkamp A.J., de Bree E., Kaag M.M., et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemo- therapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. // Eur. J. Cancer 2001. - № 37. – P. 979–984.


34. Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.// Am. Surg. 2000. - № 66. – P. 561.


35. Verwaal V.J., van Ruth S, de Bree E etal. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. // J. Clin. Oncol. 2003. - № 21. - 3737– 3743.


36. Bang Y.J., Van Cutsem E, Feyereislova A et al. Trastuzumab in combi- nation with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.// Lancet 2010. - № 376. – P. 687–97.


37. Kuramoto M., Shimada S, Ikeshima S et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recur- rence in patients with gastric carcinoma. // Ann. Surg. 2009. - № 250 – P. 242–6.


38. Belyaev A.M., Bagnenko S.F., Ryhlyada N.V. Vnytribrushnaya himioterapiya zlokachestvennih opyholei brushnoi polosti: M. – SPb.: ELBI-SPb, 2007. – 254 s.


39. Tarasov V.A., Vinogradova M.V., Norbaev Sh.E., Sharov U.K., Lvov I.V., Stavrovieckii V.V., Pobochanov E.S., Blum M.B., Adyeva S.A.. Harakteristika oslojnenii posle cioredyktivnih operacii s intraoperacionnoi himiotermicheskoi perfyziei y bolnih s kanceromatozom brushini. – Sankt-Peterbyrg, 2006.


40. Sugarbaker P. H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery // Expert. Opin. Pharmacother. – 2009. – Vol. 10, № 12. – P. 1965–1977.


41. Norbaev Sh.E. Oslojneniya posle citoredyktivnih operacii s ispolzovaniem intraoperacionnoi himiogipertermicheskoi perfyzii: Avtorefer. diss. kand. med. nayk. – Sankt-Peterbyrg, 2006.


42. Yan T.D., Morris D.L. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? // Ann Surg 2008. – №248. – P. 829-835.


43. Cascales Campos P.A., Gil M.J., Galindo Fernandez P.J., et al. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer // Eur J Surg Oncol. 2011. – Vol. 37(6). - P. 543-548.


44. Namikawa T., Yatabe T., Inoue K., Shuin T., Hanazaki K., Clinical applications of 5-aminolevulinic acid-mediated fluorescence for gastric cancer.//World J Gastroenterol. 2015. - Vol. 7. - №21(29). – P. 8769-8775.


45. Rhonda L. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer // Proceeding of International Seminars in Surgical Oncology. – 2005. –P.1–10.


46. Crous A.M., Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?// Stem Cell Res Ther. 2013. – Vol.4(5). – P. 129.


47. Dougherty T.J. Photodynamic therapy // Journal of National Cancer Institute. – 1998. – Vol. 90. – R. 889–900.


48. Nowis D. Direct tumor damage mechanisms of photodynamic therapy // Photodynamic therapy. – 2005. – Vol. 52. – R. 339–352.


49. Griffin G.M. Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in canine model // Clinical Cancer Research. – 2001. – Vol. 7. – R. 374–381.


50. Veenhuizen R.B. Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma // British Journal Cancer. – 1996. – Vol. 73. – R. 1387–1392.


51. Tochner Z. Photodynamic therapy of the canine peritoneum: normal tissue response to intraperitoneal and intravenous photofrin followed by 630 nm light // Lasers Surgical Medicine. – 1991. – Vol. 11. – R. 158–164.


52. Veenhuizen R.B. Intraperitoneal photodynamic therapy: comparison of red and green light distribution and toxity // Photochemistry and photobiology. – 1997. – Vol. 66. – R. 389–395.


53. Molpus Kelly L. Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model // Cancer Research. – 1996. – Vol.56. – P.1075-1082.


54. Samanta K. Hendren. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors //Annals of Surgical Oncology. – 2001. – Vol. 1, N 8. – P. 65-71.


55. Stephen M. Hahn. A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis // Clinical Cancer Research. – 2006. – Vol. 8. – R. 2517–2525.


56. Sajin V.P. Fotodinamicheskaya terapiya brushini: pervii opit // Rossiiskii bioterapevticheskii jyrnal. – 2007. – T. 6, No 1. – S. 24–25.


57. Grishin N.A. Metodicheskie aspekti laparoskopicheskoi fotodinamicheskoi terapii brushini y onkologicheskih bolnih // Tezisi VII Rossiiskogo sezda endohiryrgov. – Moskva, 2004.


58. Vakylovskaya E. G. Sovremennie vozmojnosti fluorescentnoi diagnostiki i fotodinamicheskoi terapii // Vestnik Moskovskogo Onkologicheskogo Obshestva. – 2007. - N 4.


59. Heldin C.H. High interstitial fluid pressure - an obstacle in cancer therapy // Nat Rev Cancer. 2004. - Vol. 4. - № 8. - P. 806-813.


60. Bouvy N.D. ANNALS OF SURGERY // 1994. - Vol. 224. - №. 6. - P. 694-701.


61 Jacquet R. Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration // Anti-Cancer drugs, 1996.


62. Reymond M. A. Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator // Surg Endoscopy, 2000. - № 14. - P. 51–55.


63. Alkhamesi A. A novel technique for delivering intraperitoneal therapeutics in laparoscopic surgery to prevent locoregional recurrence // Surg Endoscopy, 2005. - № 19. - P. 1142–1146.


64. Alkhamesi A. Intraperitoneal aerosolization of bupivacaine reduces postoperative pain in laparoscopic surgery: a randomized prospective controlled double-blinded clinical trial // Surg Endoscopy, 2007. - № 21 - P. 602–606.


65. Esquis P., Consolo D., Magnin G., Pointaire P., Moretto P., Ynsa MD., Beltramo J.L., Drogoul C., Simonet M., Benoit L., Rat P., Chauffert B. : High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis //Ann Surg, 2006. - № 244 - P. 106-112.


66. Reymond M.A. Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy // Ann Surg Oncol, 2014. - № 21. – P. 553–559.


67. Tempfer B. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study // Gynecologic Oncology Reports 12/2014. - 2015.

Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций

(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции